Cutaneous amyloid is a biomarker in early <scp>ATTRv</scp> neuropathy and progresses across disease stages-Reference-Cited by-同舟云学术

Cutaneous amyloid is a biomarker in early ATTRv neuropathy and progresses across disease stages

Published:2022-08-09 Issue:9 Volume:9 Page:1370-1383
ISSN:2328-9503
Container-title:Annals of Clinical and Translational Neurology
language:en
Short-container-title:Ann Clin Transl Neurol

Author:

Freeman Roy¹^ORCID,Gonzalez‐Duarte Alejandra²,Barroso Fabio³,Campagnolo Marta¹,Rajan Sharika¹,Garcia Jennifer¹,Kim Jee Young¹,Wang Ningshan¹,Orellana Lucas³,Gibbons Christopher¹^ORCID

Affiliation:

1. Beth Israel Deaconess Medical Center, Harvard Medical School Boston Massachusetts USA

2. Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán Mexico

3. Raúl Carrea Institute for Neurological Research, FLENI Ciudad Autónoma de Buenos Aires Argentina

Funder

Pfizer

Publisher

Wiley

Subject

Neurology (clinical),General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acn3.51636

Reference36 articles.

1. Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease

2. Hereditary ATTR amyloidosis: burden of illness and diagnostic challenges;Gertz MA;Am J Manag Care,2017

3. Clinical presentations and skin denervation in amyloid neuropathy due to transthyretin Ala97Ser

4. Sudomotor innervation in transthyretin amyloid neuropathy: Pathology and functional correlates

5. Cutaneous nerve biomarkers in transthyretin familial amyloid polyneuropathy

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenotypic presentation of family members of ATTRv probands and subsequent disease penetrance;2024-09-07

2. Amyloid Neuropathy: From Pathophysiology to Treatment in Light‐Chain Amyloidosis and Hereditary Transthyretin Amyloidosis;Annals of Neurology;2024-06-24

3. Early diagnosis in ATTRv amyloidosis, how early is enough? How early is possible?;Medicina Clínica;2024-06

4. Early diagnosis in ATTRv amyloidosis, how early is enough? How early is possible?;Medicina Clínica (English Edition);2024-06

5. Prevalence and disease burden of peripheral neuropathy in the general population in Mexico city: a cross-sectional epidemiological study;Current Medical Research and Opinion;2024-05-31